Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation

Gut

Volumn 53, Issue 12, 2004, Pages 1832-1836

  Sturt, N J H ^a   Gallagher, M C ^a   Bassett, P ^b   Philp, C R ^a   Neale, K F ^a   Tomlinson, I P M ^a,c   Silver, A R J ^a   Phillips, R K S ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

^b Statistics Consultancy   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN;

ABDOMINAL SURGERY; ADENOMATOUS POLYP; ALLELISM; ARTICLE; CHEMOPROPHYLAXIS; CODON; COLON RESECTION; DESMOID TUMOR; FAMILY HISTORY; FEMALE; GENDER; GENE MUTATION; GENETIC PREDISPOSITION; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; COLECTOMY; FEMALE; FIBROMATOSIS, ABDOMINAL; GENES, APC; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LOGISTIC MODELS; MALE; NEOPLASMS, SECOND PRIMARY; RISK FACTORS;

EID: 9344261842     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.042705     Document Type: Article

References (31)

1. Miyoshi Y, Iwao K, Nawa G, et al. Frequent mutations in the beta-catenin gene in desmoid tumours from patients without familial adenomatous polyposis. Oncol Res 1998;10:591-4.
2. Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis. Oncogene 1999;18:6615-20.
3. Gurbuz AK, Giardello FM, Petersen GM, et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994;35:377-81.
4. Nugent KP, Spigelman AD, Phillips RKS. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1993;36:1059-62.
5. Arvanitis ML, Jagelman DG, Fazio VW, et al. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990;33:639-42.
6. Bertario L, Presciuttini S, Sala P, et al. Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian registry of familial polyposis writing committee. Semin Surg Oncol 1994;10:225-34.
7. Clark SK, Neale KF, Landgrebe JC, et al. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 1999;86:1185-9.
8. McAdam WA, Goligher JC. The occurrence of desmoids in patients with familial polyposis coli. Br J Surg 1970;57:618-31.
9. Mace J, Sybil BJ, Sondak V, et al. Response of extraabdominal desmoid tumors to therapy with imatinib mesylate. Cancer 2002;95:2373-9.
10. Bertario L, Russo A, Sala P, et al. Genotype and phenotype factors as determinants of desmoid tumours in patients with familial adenomatous polyposis. Int J Cancer 2001;95:102-7.
11. Soravia C, Berk T, McLeod RS, et al. Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum 2000;43:363-9.
12. Caspari R, Olschwang S, Friedl W, et al. Familial adenomatous polyposis: desmoid tumours and lack of opthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Human Mol Genet 1995;4:337-340.
13. Davies DR, Armstrong JG, Thakker N, et al. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 1995;57:1151-8.
14. Scott RJ, Froggatt NJ, Trembath RC, et al. Familial infiltrative fibromatosis (desmoid tumours) (MIM1 35290) caused by a recurrent 3′ APC gene mutation. Hum Mol Genet 1996;5:1921-4.
15. Miyaki M, Konishi M, Kikuchi-Yanoshita R, et al. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumours from patients with familial adenomatous polyposis. Cancer Res 1993;53:5079-82.
16. Palmirotta R, Curia MC, Esposito DL, et al. Novel mutations and inactivation of bath alleles of the APC gene in desmoid tumours. Hum Mol Genet 1995;4:1979-81.
17. Lamlum H, Ilyas M, Rowan A, et al. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of germline mutation: a new facet to Knudson's 'two hit' hypothesis. Nat Med 1999;5:1071-5.
18. Albuquerque C, Breukel C, van der Luijt R, et al. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 2002;11:1549-60.
19. Crabtree M, Sieber OM, Lipton L, et al. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients. Oncogene 2003;22:4257-65.
20. Haulston R, Crabtree M, Phillips R, et al. Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes. Gut 2000;48:1-5.
21. Graves C, Lamlum H, Crabtree M, et al. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 2002;160:2055-61.
22. Nagase H, Miyoshi Y, Horri A, et al. Correlation between the location of germline mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res 1992;52:4055-7.
23. van der Luijt RB, Meera Khan P, Vasen HFA, et al. Germline mutations in the 3′ part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Hum Genet 1996;98:727-34.
24. Soravia C, Berk T, Madlensky L, et al. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 1998;62:1290-301.
25. Tolg C, Poon R, Fodde R, et al. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumour). Oncogene 2003;22:6873-82.
26. Caldwell EH. Desmoid tumor: musculoaponeurotic fibrosis of the abdominal wall. Surgery 1976;79:104-6.
27. Eagel BA, Zentler-Munro P, Smith IE. Mesenteric desmoid tumours in Gardner's syndrome - review of medical treatments. Postgrad Med J 1989;65:497-501.
28. Tonelli F, Valanzano R, Brandi ML. Pharmacologic treatment of desmoid tumors in familial adenomatous polyposis: results of an in vitro study. Surgery 1994;115:473-9.
29. Klemmer S, Pascoe L, Decosse J. Occurrence of desmoids in patients with familial adenomatous polyposis of the colon. Am J Med Genet 1987;28:385-92.
30. Lofti AM, Dozois RR, Gordon H, et al. Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment. Int J Colorectal Dis 1989;4:30-6.
31. Friedl W, Caspari R, Sengteller M, et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 2001;48:515-21.